---
$id: https://graph.org.ai/products/commodity/51281907
$type: Product
source: UNSPSC
code: "51281907"
title: "Rufocromomycin or streptonigrin"
class: "51281900"
classTitle: "Antineoplastics"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Rufocromomycin or streptonigrin

**UNSPSC Code**: 51281907
**Class**: [Antineoplastics](Antineoplastics.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antineoplastic antibiotic with the molecular structure C25H22N4O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 261Q3JB310 chemically known as 2-pyridinecarboxylic acid, 5-amino-6-(7-amino-5,8-dihydro-6-methoxy-5,8-dioxo-2-quinolinyl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methyl- but generally known as rufocromomycin, which bears US NIH Compound Identifier 5323583. European Medicines Agency schedules Rufocromomycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10405MIG. The term RUFOCROMOMYCIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, no. 10 1975, list 15. ). Rufocromomycin or streptonigrin bears US NLM identifiers UMLS ID C0038427 and NCI Concept Code C844. SMILES: O(C1=C(OC)C=CC(=C2\C(C([NH]C(C2N)C2NC3C(CC2)C(=O)C(=C(N)C3=O)OC)C(=O)O)C)\C1=O)C.

